Literature DB >> 6847819

Role of vasopressin in blood pressure regulation during adrenal insufficiency.

J Schwartz, L C Keil, J Maselli, I A Reid.   

Abstract

The effect of adrenal insufficiency on the plasma concentrations of two vasoactive hormones, vasopressin and angiotensin II, was studied in conscious dogs. In addition the role of vasopressin in the maintenance of blood pressure during adrenal insufficiency was studied using [1-(beta-mercapto-beta, beta-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine]arginine vasopressin, a specific antagonist of the vasoconstrictor action of vasopressin. Dogs were bilaterally adrenalectomized and maintained on daily cortisol and deoxycorticosterone acetate injections. Withdrawal of steroids for 4 days resulted in a 4-fold increase in plasma vasopressin concentration (P less than 0.05) and a 3-fold increase in plasma angiotensin II concentration (P less than 0.001); mean arterial pressure did not change significantly. Administration of the vasopressin antagonist in adrenalectomized dogs maintained on steroids had no effect on blood pressure. In marked contrast, vasopressin blockade in dogs with adrenal insufficiency decreased mean arterial pressure by 22 +/- 5 mm Hg (P less than 0.001). These results demonstrate the plasma angiotensin II and vasopressin concentrations increase during adrenal insufficiency in conscious dogs, and that vasopressin plays an important role in blood pressure regulation in this hypovolemic state.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6847819     DOI: 10.1210/endo-112-1-234

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Excitation of the cardiac vagus by vasopressin in mammals.

Authors:  G P Courtice; T E Kwong; E R Lumbers; E K Potter
Journal:  J Physiol       Date:  1984-09       Impact factor: 5.182

2.  Pattern Recognition versus Pathogenesis: Electrolytes in a Patient with Adrenal Insufficiency.

Authors:  Melanie P Hoenig; Stewart H Lecker
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-03       Impact factor: 8.237

3.  Copeptin Levels Before and After Transsphenoidal Surgery for Cushing Disease: A Potential Early Marker of Remission.

Authors:  Chelsi Flippo; Christina Tatsi; Ninet Sinaii; Maria De La Luz Sierra; Elena Belyavskaya; Charalampos Lyssikatos; Meg Keil; Elias Spanakis; Constantine A Stratakis
Journal:  J Endocr Soc       Date:  2022-04-06

Review 4.  Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis.

Authors:  Matthias Lange; Christian Ertmer; Martin Westphal
Journal:  Intensive Care Med       Date:  2007-12-08       Impact factor: 17.440

5.  Metyrapone induced increase in plasma corticotropin is not associated with changes in peripheral venous arginine vasopressin or corticotropin releasing factor.

Authors:  S J Holmes; C M Florkowski; M J Evans; M J Ellis; J H Livesey; R A Donald; E A Espiner
Journal:  J Endocrinol Invest       Date:  1993-11       Impact factor: 4.256

6.  Vasopressin-mediated forearm vasodilation in normal humans. Evidence for a vascular vasopressin V2 receptor.

Authors:  A T Hirsch; V J Dzau; J A Majzoub; M A Creager
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

Review 7.  Treatment of severe sepsis: where next? Current and future treatment approaches after the introduction of drotrecogin alfa.

Authors:  Todd W Rice
Journal:  Vasc Health Risk Manag       Date:  2006
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.